New Pyridone-Based Derivatives as Cannabinoid Receptor Type 2 Agonists

The activation of the human cannabinoid receptor type II (CB2R) is known to mediate analgesic and anti-inflammatory processes without the central adverse effects related to cannabinoid receptor type I (CB1R). In this work we describe the synthesis and evaluation of a novel series of N-aryl-2-pyridon...

Descripción completa

Detalles Bibliográficos
Autores principales: Faundez Parraguez, Manuel, Alarcon Miranda, Carlos, Cho, Young Hwa, Pessoa Mahana, Hernan, Gallardo Garrido, Carlos, Chung, Hery, Faundez, Mario, Pessoa Mahana, David
Formato: Artículo (Article)
Idioma:Inglés (English)
Publicado: MDPI 2024
Materias:
Acceso en línea:https://repositorio.uc.cl/handle/11534/80023